Expression of EIF3-p48/INT6, TID1 and Patched in cancer, a profiling of multiple tumor types and correlation of expression

Journal of Biomedical Science

Volumn 14, Issue 3, 2007, Pages 395-405

  Traicoff, June L ^a,f   Chung, Joon Yong ^b,e   Braunschweig, Till ^b   Mazo, Ilya ^c   Shu, Youmin ^d   Ramesh, Arun ^a   D'Amico, Mark W ^a   Galperin, Mikhail M ^a   Knezevic, Vladimir ^a   Hewitt, Stephen M ^b  

^a 20/20 Gene Systems   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c Ariadne Genomics Inc   (United States)

^d TissueGene Inc   (United States)

^e Inje University   (South Korea)

^f SAIC FREDERICK INC   (United States)

Author keywords

INT6; Layered expression scanning; MLWestern; Multiplex tissue immunoblotting; Patched; TID1

Indexed keywords

INITIATION FACTOR 3; PROTEIN P48; PROTEIN PATCHED; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR INT6; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; DNAJA3 PROTEIN, HUMAN; HEAT SHOCK PROTEIN 40; ONCOPROTEIN; PATCHED RECEPTORS; TUMOR MARKER;

ARTICLE; BREAST CANCER; CARCINOGENESIS; COLON CANCER; CONTROLLED STUDY; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; LUNG CANCER; MICROARRAY ANALYSIS; OVARY CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; TISSUE MICROARRAY; TISSUE SPECIFICITY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOPLASM; PATHOLOGY;

EUKARYOTIC INITIATION FACTOR-3; GENE EXPRESSION REGULATION, NEOPLASTIC; HSP40 HEAT-SHOCK PROTEINS; HUMANS; NEOPLASMS; PROTO-ONCOGENE PROTEINS; RECEPTORS, CELL SURFACE; TUMOR MARKERS, BIOLOGICAL;

EID: 34548554292     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/s11373-007-9149-3     Document Type: Article

References (54)

1. Marchetti A., Buttitta F., Miyazaki S., Gallahan D., Smith G.H. and Callahan R., Int-6, a highly conserved, widely expressed gene, is mutated by mouse mammary tumor virus in mammary preneoplasia. J. Virol. 69(3) 1932-1938, 1995.
2. Mayeur G.L. and Hershey J.W., Malignant transformation by the eukaryotic translation initiation factor 3 subunit p48 (eIF3e). FEBS Lett. 514(1) 49-54, 2002.
3. Rasmussen S.B., Kordon E., Callahan R. and Smith G.H., Evidence for the transforming activity of a truncated Int6 gene, in vitro. Oncogene 20(38) 5291-5301, 2001.
4. Marchetti A., Buttitta F., Pellegrini S., Bertacca G and Callahan R., Reduced expression of INT-6/eIF3-p48 in human tumors. Int. J. Oncol. 18(1) 175-179, 2001.
5. Buttitta F., Martella C, Barassi F., Felicioni L., Salvatore S., Rosini S., DAntuono T., Chella A., Mucilli F., Sacco R., Mezzetti A., Cuccurullo F., Callahan R. and Marchetti A., Int6 expression can predict survival in early-stage non-small cell lung cancer patients. Clin. Cancer Res. 11(9) 3198-3204, 2005.
6. Bandyopadhyay A., Matsumoto T. and Maitra U., Fission yeast Int6 is not essential for global translation initiation, but deletion of int6(+) causes hypersensitivity to caffeine and affects spore formation. Mol. Biol. Cell. 11(11) 4005-4018, 2000.
7. Yen H.C. and Chang E.C., Yin6, a fission yeast Int6 homolog, complexes with Moe1 and plays a role in chromosome segregation. Proc. Natl. Acad. Sci. USA 97(26) 14370-14375, 2000.
8. Crane R., Craig R., Murray R., Dunand-Sauthier I., Humphrey T. and Norbury C, A fission yeast homolog of Int-6, the mammalian oncoprotein and eIF3 subunit, induces drug resistance when overexpressed. Mol. Biol. Cell 11(11) 3993-4003, 2000.
9. Guo J. and Sen G.C., Characterization of the interaction between the interferon-induced protein P56 and the Int6 protein encoded by a locus of insertion of the mouse mammary tumor virus. J. Virol. 74(4) 1892-1899, 2000.
10. Yahalom A., Kim T.H., Winter E., Karniol B., von Arnim A.G and Chamovitz DA., Arabidopsis eIF3e (INT-6) associates with both eIF3c and the COP9 signalosome subunit CSN7. J. Biol. Chem. 276(1) 334-340, 2001.
11. Desbois C., Rousset R., Bantignies F. and Jalinot P., Exclusion of Int-6 from PML nuclear bodies by binding to the HTLV-I Tax oncoprotein. Science 273(5277) 951-953, 1996.
12. Morris-Desbois C., Bochard V., Reynaud C. and Jalinot P., Interaction between the Ret finger protein and the Int-6 gene product and co-localisation into nuclear bodies. J. Cell Sci. 112(Pt 19) 3331-3342, 1999.
13. Hoareau Alves K., Bochard V., Rety S. and Jalinot P., Association of the mammalian proto-oncoprotein Int-6 with the three protein complexes eIF3, COP9 signalosome and 26S proteasome. FEBS Lett. 527(1-3) 15-21, 2002.
14. Yen H.C., Gordon C. and Chang E.C., Schizosaccharomyces pombe Int6 and Ras homologs regulate cell division and mitotic fidelity via the proteasome. Cell 112(2) 207-217, 2003.
15. Hewitt S.M., Dear J. and Star R.A., Discovery of protein biomarkers for renal diseases. J. Am. Soc. Nephrol. 15(7) 1677-1689, 2004.
16. Xiao Z., Prieto D., Conrads T.P., Veenstra T.D. and Issaq H.J., Proteomic patterns: their potential for disease diagnosis. Mol. Cell. Endocrinol. 230(1-2) 95-106, 2005.
17. Mikolajczyk S.D., Song Y., Wong J.R., Matson R.S. and Rittenhouse H.G., Are multiple markers the future of prostate cancer diagnostics?. Clin. Biochem. 37(7) 519-528, 2004.
18. Perez E.A., Pusztai L. and Van de Vijver M., Improving patient care through molecular diagnostics. Semin. Oncol. 31(5 Suppl 10) 14-20, 2004.
19. Chung J.Y., Braunschweig T., Baibakov G., Galperin M., Ramesh A., Skacel M., Gannot G., Knezevic V. and Hewitt S.M., Transfer and multiplex immunoblotting of a paraffin embedded tissue. Proteomics 6(3) 767-774, 2006.
20. Chung J.Y., Braunschweig T., Hu N., Roth M., Traicoff J.L., Wang Q.H., Knezevic V., Taylor P.R. and Hewitt S.M., A multiplex tissue immunoblotting assay for proteomic profiling: a pilot study of the normal to tumor transition of esophageal squamous cell carcinoma. Cancer Epidemiol. Biomarkers Prev. 15(7) 1403-1408, 2006.
21. Chung J.Y., Braunschweig T., Tuttle K. and Hewitt S.M., Tissue microarrays as a platform for proteomic investigation. J. Mol. Histol. 2006 (e-pub).
22. Watkins S.J. and Norbury C.J., Cell cycle-related variation in subcellular localization of eIF3e/INT6 in human fibroblasts. Cell Prolif. 37(2) 149-160, 2004.
23. Canamasas I., Debes A., Natali P.G. and Kurzik-Dumke U., Understanding human cancer using Drosophila: Tid47, a cytosolic product of the DnaJ-like tumor suppressor gene l2Tid, is a novel molecular partner of patched related to skin cancer. J. Biol. Chem. 278(33) 30952-30960, 2003.
24. Trentin G.A., Yin X., Tahir S., Lhotak S., Farhang-Fallah J., Li Y. and Rozakis-Adcock M., A mouse homologue of the Drosophila tumor suppressor l(2)tid gene defines a novel Ras GTPase-activating protein (RasGAP)-binding protein. J. Biol. Chem. 276(16) 13087-13095, 2001.
25. Perdomo J., Verger A., Turner J. and Crossley M., Role for SUMO modification in facilitating transcriptional repression by BKLF. Mol. Cell. Biol. 25(4) 1549-1559, 2005.
26. Gomez-Lazaro M., Fernandez-Gomez F.J. and Jordan J., p53: twenty five years understanding the mechanism of genome protection. J. Physiol. Biochem. 60(4) 287-307, 2004.
27. Sarkar S., Pollack B.P., Lin K.T., Kotenko S.V., Cook J.R, Lewis A. and Pestka S., hTid-1, a human DnaJ protein, modulates the interferon signaling pathway. J. Biol. Chem. 276(52) 49034-49042, 2001.
28. Porta C., Hadj-Slimane R., Nejmeddine M., Pampin M., Tovey M.G., Espert L., Alvarez S. and Chelbi-Alix M.K., Interferons alpha and gamma induce p53-dependent and p53-independent apoptosis, respectively. Oncogene 24(4) 605-615, 2005.
29. Takaoka A., Hayakawa S., Yanai H., Stoiber D., Negishi H., Kikuchi H., Sasaki S., Imai K., Shibue T., Honda K. and Taniguchi T., Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence. Nature 424(6948) 516-523, 2003.
30. Malmgaard L., Induction and regulation of IFNs during viral infections. J. Interferon Cytokine Res. 24(8) 439-454, 2004.
31. Naumann M., Bech-Otschir D., Huang X., Ferrell K. and Dubiel W., COP9 signalosome-directed c-Jun activation/stabilization is independent of JNK. J. Biol. Chem. 274(50) 35297-35300, 1999.
32. Uhle S., Medalia O., Waldron R., Dumdey R., Henklein P., Bech-Otschir D., Huang X., Berse M., Sperling J., Schade R. and Dubiel W., Protein kinase CK2 and protein kinase D are associated with the COP9 signalosome. EMBO J. 22(6) 1302-1312, 2003.
33. Yoneda-Kato N., Tomoda K., Umehara M., Arata Y. and Kato J.Y., Myeloid leukemia factor 1 regulates p53 by suppressing COP1 via COP9 signalosome subunit 3. EMBO J. 24(9) 1739-1749, 2005.
34. Banda N.K., Guthridge C., Sheppard D., Cairns K.S., Muggli M., Bech-Otschir D., Dubiel W. and Arend W.P., Intracellular IL-1 receptor antagonist type 1 inhibits IL-1-induced cytokine production in keratinocytes through binding to the third component of the COP9 signalosome. J. Immunol. 174(6) 3608-3616, 2005.
35. Tomoda K., Kubota Y., Arata Y., Mori S., Maeda M., Tanaka T., Yoshida M., Yoneda-Kato N. and Kato J.Y., The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1/CSN5 and the COP9 signalo-some complex. J. Biol. Chem. 277(3) 2302-2310, 2002.
36. Burger-Kentischer A., Finkelmeier D., Thiele M., Schmucker J., Geiger G., Tovar G.E. and Bernhagen J., Binding of JAB1/CSN5 to MIF is mediated by the MPN domain but is independent of the JAMM motif. FEBS Lett. 579(7) 1693-1701, 2005.
37. Cheng H., Cenciarelli C., Shao Z., Vidal M., Parks W.P., Pagan M. and Cheng-Mayer C., Human T cell leukemia virus type 1 Tax associates with a molecular chaperone complex containing hTid-1 and Hsp70. Curr. Biol. 11(22) 1771-1775, 2001.
38. Grassmann R., Aboud M. and Jeang K.T., Molecular mechanisms of cellular transformation by HTLV-1 Tax. Oncogene 24(39) 5976-5985, 2005.
39. Jeang K.T., Giam C.Z., Majone F. and Aboud M., Life, death, and tax: role of HTLV-I oncoprotein in genetic instability and cellular transformation. J. Biol. Chem. 279(31) 31991-31994, 2004.
40. Van P.L., Yim K.W., Jin D.Y., Dapolito G., Kurimasa A. and Jeang K.T., Genetic evidence of a role for ATM in functional interaction between human T-cell leukemia virus type 1 Tax and p53. J. Virol. 75(1) 396-407, 2001.
41. Jeong S.J., Radonovich M., Brady J.N. and Pise-Masison C.A., HTLV-I Tax induces a novel interaction between p65/RelA and p53 that results in inhibition of p53 transcriptional activity. Blood 104(5) 1490-1497, 2004.
42. Englert C.R., Baibakov G.V. and Emmert-Buck M.R., Layered expression scanning: rapid molecular profiling of tumor samples. Cancer Res. 60(6) 1526-1530, 2000.
43. Galperin M.M., Traicoff J.L., Ramesh A., Freebern W.J., Haggerty C.M., Hartmann D.P., Emmert-Buck M.R., Gardner K. and Knezevic V., Multimembrane dot-blotting: a cost-effective tool for proteome analysis. Biotechniques 36(6) 1046-1051, 2004.
44. Traicoff J.L., Galperin M.M., Ramesh A., Freebern W.J., Haggerty C.M., Gardner K. and Knezevic V., Profiling the expression of mitogen-induced T-cell proteins by using multi-membrane dot-blotting. Biochem. Biophys. Res. Commun. 323(1) 355-360, 2004.
45. Traicoff J.L., Baibakov G., Biesecker G., Richardson F., Ramesh A., Galperin M.M., Iwata K.K. and Knezevic V., Novel application of layered expression scanning for proteomic profiling of plucked hair follicles. Dermatology 210(4) 273-278, 2005.
46. Miller W.J., Kayton M.L., Patton A., O'Connor S., He M., Vu H., Baibakov G., Lorang D., Knezevic V., Kohn E., Alexander H.R., Stirling D., Payvandi F., Muller G.W. and Libutti S.K., A novel technique for quantifying changes in vascular density, endothelial cell proliferation and protein expression in response to modulators of angiogenesis using the chick chorioallantoic membrane (CAM) assay. J. Transl. Med. 2(1) 4, 2004.
47. Barnes E.A., Kong M., Ollendorff V. and Donoghue D.J., Patched1 interacts with cyclin B1 to regulate cell cycle progression. EMBO J. 20(9) 2214-2223, 2001.
48. Fehrmann F. and Laimins L.A., Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation. Oncogene 22(33) 5201-5207, 2003.
49. Yang X., Menon S., Lykke-Andersen K., Tsuge T., Di X., Wang X., Rodriguez-Suarez R.J., Zhang H. and Wei N., The COP9 signalosome inhibits p27(kip1) degradation and impedes G1-S phase progression via deneddylation of SCF Cul1. Curr. Biol. 12(8) 667-672, 2002.
50. Dho S.H. and Kwon K.S., The Ret finger protein induces apoptosis via its RING finger-B box-coiled-coil motif. J. Biol. Chem. 278(34) 31902-31908, 2003.
51. Syken J., De-Medina T. and Munger K., TID1, a human homolog of the Drosophila tumor suppressor l(2)tid, encodes two mitochondrial modulators of apoptosis with opposing functions. Proc. Natl. Acad. Sci. USA 96(15) 8499-8504, 1999.
52. Syken J., Macian F., Agarwal S., Rao A. and Munger K., TID1, a mammalian homologue of the drosophila tumor suppressor lethal(2) tumorous imaginal discs, regulates activation-induced cell death in Th2 cells. Oncogene 22(30) 4636-4641, 2003.
53. Edwards K.M. and Munger K., Depletion of physiological levels of the human TID1 protein renders cancer cell lines resistant to apoptosis mediated by multiple exogenous stimuli. Oncogene 23(52) 8419-8431, 2004.
54. Guerrero I. and Ruiz i Altaba A., Development. Longing for ligand: hedgehog, patched, and cell death. Science 301(5634) 774-776, 2003.